Mae'r adroddiad gan yr elusen wedi'i ddiweddaru (ar amser)
Dogfen lywodraethu
Manylion am y math o ddogfen lywodraethu sydd gan yr elusen a phan y'i sefydlwyd. Nid dyma destun llawn dogfen lywodraethu'r elusen.
CIO - FOUNDATION Registered 29 May 2020 as amended on 16 Feb 2021 as amended on 14 Jun 2021
Gwrthrychau elusennol
THE OBJECT OF THE CIO IS:
TO PRESERVE AND PROTECT THE GOOD HEALTH OF UK EPIDERMAL GROWTH FACTOR RECEPTOR (EGFR) POSITIVE LUNG CANCER PATIENTS BY:-
A. PROVIDING AN INFORMATION RESOURCE, IN PARTICULAR ACCESS TO INFORMATION ABOUT LATEST DEVELOPMENTS AND CLINICAL TRIALS;
B. IDENTIFYING AND LOCATING UK EGFR PATIENTS AND OFFERING SUPPORT AND GUIDANCE ON THE LOCATION OF UK EGFR SPECIALISTS AND SERVICES;
C. LIAISING WITH AND INFLUENCING DECISION MAKERS, E.G. NICE, NHS, DVLA;
D. RAISING AWARENESS OF EGFR LUNG CANCER, PARTICULARLY AMONGST THE MEDICAL PROFESSION SO AS TO PROMOTE
THE BEST TREATMENT FOR PATIENTS;
E. LIAISING WITH RELEVANT ORGANISATIONS, IN PARTICULAR ROY CASTLE LUNG CANCER FOUNDATION AND THE PHARMACEUTICAL INDUSTRY;
F. RAISING FUNDS FOR THE ABOVE PURPOSES.
